Detalhe da pesquisa
1.
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer.
Cancer Sci
; 115(5): 1656-1664, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450844
2.
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer.
Oncologist
; 29(5): e681-e689, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38241181
3.
Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer.
Cancer Immunol Immunother
; 72(6): 1699-1707, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36617602
4.
Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer.
Support Care Cancer
; 31(5): 308, 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115357
5.
Clinical characteristics of adrenal crisis in adult population with and without predisposing chronic adrenal insufficiency: a retrospective cohort study.
BMC Endocr Disord
; 17(1): 58, 2017 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28893233
6.
Respiratory complications of Stevens-Johnson syndrome (SJS): 3 cases of SJS-induced obstructive bronchiolitis.
Allergol Int
; 69(3): 465-467, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067932
7.
[International comparison and regulatory issues of the molecular targeted therapy development].
Nihon Rinsho
; 73(8): 1403-8, 2015 Aug.
Artigo
em Japonês
| MEDLINE | ID: mdl-26281697
8.
Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database.
J Gastroenterol
; 59(2): 145-156, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006445
9.
Efficacy and Safety of Docetaxel plus Ramucirumab for Patients with Pretreated Advanced or Recurrent Non-small Cell Lung Cancer: Focus on Older Patients.
Target Oncol
; 19(3): 411-421, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467958
10.
Comparing Three Different Anti-Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study.
JTO Clin Res Rep
; 5(3): 100644, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444594
11.
Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50.
Front Immunol
; 15: 1348034, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464519
12.
Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor: Comparison between T790M mutation-positive and mutation-negative populations.
Cancer
; 119(24): 4325-32, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105277
13.
A phase II study of pemetrexed in chemotherapy-naive elderly patients aged ≥ 75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003).
Jpn J Clin Oncol
; 43(12): 1184-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24168805
14.
Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib: A case report.
Respirol Case Rep
; 11(9): e01208, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614813
15.
Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high PD-L1 expression (SPIRAL-3D study).
Ther Adv Med Oncol
; 15: 17588359231177022, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333903
16.
Recurrence of Large-Vessel Vasculitis Induced by Multiple Types of Granulocyte Colony-Stimulating Factor Preparation in Patient with Large-Cell Neuroendocrine Lung Carcinoma: A Case Report.
Case Rep Oncol
; 16(1): 771-778, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37900825
17.
Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer: A Prospective Exploratory Study.
Target Oncol
; 18(5): 657-665, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37610516
18.
Analysis of Tumor Heterogeneity Through AXL Activation in Primary Resistance to EGFR Tyrosine Kinase Inhibitors.
JTO Clin Res Rep
; 4(6): 100525, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37426308
19.
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan.
J Gastroenterol
; 58(6): 575-585, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029223
20.
Early Tumor Shrinkage as a Predictor of Favorable Treatment Outcomes in Patients With Extensive-Stage SCLC Who Received Programmed Cell Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy: A Prospective Observational Study.
JTO Clin Res Rep
; 4(4): 100493, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37025120